Giuseppina Perrone

ORCID: 0000-0002-9152-3047 · 6 papers in corpus · active 1994-2020

Study types

  • article 6
article 2020
Treatment with Gonadotropin Releasing Hormone Agonists in Systemic Lupus Erythematosus Patients Receiving Cyclophosphamide: A Long-term Follow-up Study.

BACKGROUND: Cyclophosphamide treatment has been associated with ovarian function impairment. Co-treatment with gonadotropin-releasing hormone-analogue (GnRH-a) seems to be able to prevent this complication. However, even though data are ava…

article 2018
FRI0390 Impaired ovarian reserve in patients affected by systemic lupus erythematosus: a case-control study
·doi:10.1136/annrheumdis-2018-eular.4936
article 2001
Influence of vaginal danazol on uterine and brain perfusion during hormonal replacement therapy
·doi:10.1097/00042192-200111000-00007

OBJECTIVE: To evaluate the effectiveness of vaginal danazol as progestin supplement to estrogen replacement therapy, and its interference with uterine and carotid artery flow compared with medroxyprogesterone-acetate (MPA), estrogen alone, …

article 2000
Influence of vaginal danazol on uterine and brain perfusion during hormonal replacement therapy
·doi:10.1016/s0020-7292(00)84698-6
article 1995
[Effect of GnRH analogues on bone density in the vertebral column and the femur].

The objective of this study was to evaluate the effect on vertebral and femural bone density of the gonadotropin-releasing hormone (GnRH) analog administration. The changes in mineral bone density after 6 months discontinuation of the GnRH …

article 1994
[Echographic monitoring of the endometrium with a transvaginal probe in the menopause. A clinical study of 185 women in the menopause].

The aim of our study was to verify the efficacy of transvaginal ultrasound scanning as an indicator of the endometrial status in healthy menopausal women. One hundred eighty five healthy women in natural menopause were examined by vaginal s…